The SARS-CoV-2 antibody rapid test developed by FENGHUA has applied for CE marks !
On 20th March , FENGHUA has completed the application of CE mark for SARS-CoV-2 IgM/IgG Combo Rapid Test Kit.FENGHUA SARS-CoV-2 IgM/IgG Combo Rapid Test Kit is an immunochromatographic assay for rapid, qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG/IgM antibody in human whole blood, serum or plasma sample. The test is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.
As one of the leading companies of IVD industry in China, FENGHUA has always been devoting us to provide high quality health care service. And we can offers best-in-class technologies for clinical analysis by immunoassay (such as LIA, TRFIA), HPLC and mass spectrometry, and is specialized in the diagnosis of prenatal screening, neonatal screening, reproductive health, diabetes, infectious diseases, etc. We possess over 100 products (including reagents and instruments) that are CFDA-certified and CE-marked.
We have full confidence in gaining the international prestige for our outstanding-quality products and professional services.
